Cutaneous lymphoma and understanding diagnosis

Cutaneous lymphoma describes a group of conditions with different behaviours and treatments. This article focuses on cutaneous T cell lymphoma, especially mycosis fungoides, without applying its features to every type of lymphoma.

What the diagnosis means

Lymphoma arises from lymphocytes, which are cells of the immune system. A lymphoma beginning in the skin is called a primary cutaneous lymphoma. Mycosis fungoides is a cancer, not a fungal infection despite its name. It can remain limited to the skin for years in some people, while other subtypes or stages behave differently. [1][2]

Symptoms can resemble common skin conditions

Flat patches, thicker plaques, itch and colour changes may occur. These can resemble eczema or psoriasis, so neither a photograph nor itch alone establishes the diagnosis. Skin nodules or widespread redness develop in some cases. It does not spread through contact, and most persistent rashes should not automatically be assumed to be lymphoma. [1]

Why more than one biopsy may be needed

Diagnosis combines clinical examination with a skin biopsy, sometimes supported by special tests . One early biopsy may be inconclusive, so further samples may be taken from other sites or later. Repeating a biopsy does not necessarily mean progression; it may be needed to establish the diagnosis. [1][2]

Three glass microscope slides beside an open clinical folio with blank pages — A conceptual illustration of the diagnostic process; it does not depict a biopsy result or a patient.

Staging and prognosis

The clinician examines the skin and lymph nodes and may arrange blood tests, imaging or other investigations according to subtype, symptoms and examination. Staging considers skin extent and any blood, lymph-node or organ involvement. Some early stages have a very favourable outlook, but it is inaccurate to say all cases are mild or have no effect on survival. [2]

Treatment follows subtype and stage

Selected cases may be managed with structured observation or skin-directed treatment, such as topical corticosteroids, specific topical medicines, phototherapy or localized radiation. More extensive or resistant disease may need systemic or targeted medicines or other specialist procedures. Conventional chemotherapy is not the automatic treatment for every case. [1]

What to monitor between visits

Report new nodules, thickening lesions, widespread redness, enlarged lymph nodes, fever, drenching night sweats or unexplained weight loss. These findings do not prove progression by themselves, but they need assessment. Patches can recur after improvement; the clinician evaluates what recurrence means and adjusts treatment rather than assuming an outcome. [1][2]

Key point

Subtype and stage matter more than the name alone. Early mycosis fungoides can behave slowly, but every case needs appropriate assessment and follow-up. [1][2]

References

References are clickable. Accessed 2026-09-05.